Yang Lu, M.D., Ph.D.

Peer-Reviewed Articles

1. Mehta R, Cai K, Kumar N, Knuttinen MG, Anderson TM, Lu H, Lu Y. A Lesion-Based Response Prediction Model Using Pretherapy PET/CT Image Features for Y90 Radioembolization to Hepatic Malignancies. Technol Cancer Res Treat 16(5):620-629, 2017. e-Pub 2016. PMID: 27601017.
2. Sanan P, Lu Y. Multiorgan Involvement of Chemotherapy-Induced Sarcoidosis Mimicking Progression of Lymphoma on FDG PET/CT. Clin Nucl Med 42(9):702-703, 2017. PMID: 28632694.
3. Patel DC, Gunasekaran SS, Goettl C, Sweiss NJ, Lu Y. FDG PET-CT findings of extra-thoracic sarcoid are associated with cardiac sarcoid: A rationale for using FGD PET-CT for cardiac sarcoid evaluation. J Nucl Cardiol. e-Pub 2017. PMID: 28681340.
4. Qaqish A, Huang D, Chen CY, Zhang Z, Wang R, Li S, Yang E, Lu Y, Larsen MH, Jacobs WR, Qian L, Frencher J, Shen L, Chen ZW. Adoptive Transfer of Phosphoantigen-Specific γδ T Cell Subset Attenuates Mycobacterium tuberculosis Infection in Nonhuman Primates. J Immunol 198(12):4753-4763, 2017. e-Pub 2017. PMID: 28526681.
5. Bremer W, Lu Y. Delayed Tumor Seeding Along Axillary Lymph Node Biopsy Tract Visualized on FDG PET/CT. Clin Nucl Med 42(4):306-309, 2017. PMID: 28114228.
6. Wang J, Lu Y, Xia H, Yin Q. A unique procedure of joined transoral and retropharyngeal high cervical approach (JTRC) without mandibulectomy for treating upper cervical neoplasm involving both C2 and C3. Eur Spine J 26(4):1090-1095, 2017. e-Pub 2016. PMID: 27757681.
7. Lu Y. Scintigraphic Evidence for Overdiagnosis of Small PE on CT Pulmonary Angiography. Nucl Med Mol Imaging 51(1):97-98, 2017. e-Pub 2015. PMID: 28250865.
8. Lu Y, Grant C, Xie K, Sweiss NJ. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis. Clin Nucl Med 42(2):88-94, 2017. PMID: 27922863.
9. Lu Y, Patel DC, Sweiss N. Using and Interpreting F-FDG PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil Is in the Details. J Nucl Med 58(12):2039, 2017. PMID: 28663194.
10. Lu Y, Chasen BA, Macapinlac HA. Imaging Characteristics of Chemotherapy Related Adult-Onset Still Disease. Clin Nucl Med 42(12):980-982, 2017. PMID: 29076903.
11. Li L, Lu Y, Li M, Liu X, Jin P, Wang L, Sun G. Repeat Percutaneous Vertebroplasty for Recurrent Pain Arising From Previously Treated Vertebrae in Patients With Osteoporotic Vertebral Compression Fractures. Clin Spine Surg 29(9):399-404, 2016. PMID: 27755200.
12. Patel D, Anderson TM, Lu Y. FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases. Clin Nucl Med 41(9):710-1, 2016. PMID: 27187733.
13. VanDreel A, Aftab SA, Sanan P, Grant C, Lu Y. Fusion FDG-PET/MRI Evidence to Support Diagnosis of Frontotemporal Dementia-Related Primary Progressive Aphasia. Clin Nucl Med 41(9):e422-3, 2016. PMID: 26859219.
14. Elias Y, Mariano AT, Lu Y. Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT. World J Nucl Med 15(3):161-6, 2016. PMID: 27651736.
15. Patel D, Xie K, Sweiss NJ, Lu Y. Sarcoid Pericarditis and Large Vessel Vasculitis Detected on FDG PET/CT. Clin Nucl Med 41(8):661-3, 2016. PMID: 27280907.
16. Miller CT, Sweiss NJ, Lu Y. FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab. Clin Nucl Med 41(5):417-8, 2016. PMID: 26828145.
17. Mar WA, Shon AM, Lu Y, Yu JH, Berggruen SM, Guzman G, Ray CE, Miller F. Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation. Abdom Radiol (NY) 41(3):553-67, 2016. PMID: 26847022.
18. Lu Y. Overlooked Unusual Left Ventricle Metastases Detected On FDG-PET/CT. Intern Med 55(12):1673-4, 2016. e-Pub 2016. PMID: 27301527.
19. Lu Y, Sweiss NJ. MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis. Clin Nucl Med 40(12):973-4, 2015. PMID: 26544904.
20. Kumar N, Xie K, Mar W, Anderson TM, Carney B, Mehta N, Machado R, Blend MJ, Lu Y. Software-Based Hybrid Perfusion SPECT/CT Provides Diagnostic Accuracy When Other Pulmonary Embolism Imaging Is Indeterminate. Nucl Med Mol Imaging 49(4):303-11, 2015. e-Pub 2015. PMID: 26550050.
21. VanDreel A, Patel D, Emmadi R, Lu Y. FDG PET/CT Manifestation of Rare Widespread Metastatic Chemoradiation-Refractory Thymic Squamous Cell Carcinoma. Clin Nucl Med 40(11):899-901, 2015. PMID: 26252330.
22. Patel D, Lu Y. FDG-PET/CT Manifestation of Tumor Seeding Along Percutaneous Biliary Drainage Catheter Tract. Clin Nucl Med 40(10):830-1, 2015. PMID: 26098291.
23. Lu Y. Assessment of Therapy Response by (18)F-FDG PET/CT for a Patient with Cutaneous and Subcutaneous Mycobacterium Infection and Coexisting Lymphoma. Nucl Med Mol Imaging 49(2):165-6, 2015. e-Pub 2014. PMID: 26082812.
24. Lu Y. FDG and (82)Rb PET/MRI features of brain metastasis of breast cancer. Clin Nucl Med 40(6):494-5, 2015. PMID: 25674864.
25. Lu Y. An unusual right ventricle metastasis from mandible squamous cell carcinoma detected on FDG PET/CT. Clin Nucl Med 40(4):330-1, 2015. PMID: 25608149.
26. Lu Y, Groth JV, Emmadi R. Cardiac amyloidosis detected on tc-99m bone scan. Nucl Med Mol Imaging 49(1):78-80, 2015. e-Pub 2014. PMID: 25767629.
27. Cai K, Singh A, Poptani H, Li W, Yang S, Lu Y, Hariharan H, Zhou XJ, Reddy R. CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor. NMR Biomed 28(1):1-8, 2015. e-Pub 2014. PMID: 25295758.
28. Cai K, Xie K, Mar W, Palumbo A, Damen FC, Sui Y, Lu Y, Zhou Xiaohong, Knuttinen G. Normalized Relative Contrast Improves the Power of Pre-Therapy Contrast-Enhanced MRI to Predict the Prognosis of Uterine Leiomyoma Treated With Uterine Artery Embolization. J Clin Gynocol Obstet 4(1):164-9, 2015.
29. Yang AY, Lu Y. Early Diagnosis of Hepatic Hydrothorax with Associated Occlusion of a Peritoneo-Venous Shunt with Tc-99m MAA: Early Diagnosis of Hepatic Hydrothorax with Tc-99m MAA. Nucl Med Mol Imaging 48(4):330-1, 2014. e-Pub 2014. PMID: 26396643.
30. Lu Y, Lorenzoni A, Fox JJ, Rademaker J, Vander Els N, Grewal RK, Strauss HW, Schöder H. Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism. Chest 145(5):1079-1088, 2014. PMID: 24798835.
31. Gaba RC, Zivin SP, Dikopf MS, Parvinian A, Casadaban LC, Lu Y, Bui JT. Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting. Radiology 271(2):602-12, 2014. e-Pub 2014. PMID: 24533871.
32. Zivin S, David O, Lu Y. Sarcoidosis mimicking metastatic breast cancer on FDG PET/CT. Intern Med 53(21):2555-6, 2014. e-Pub 2014. PMID: 25366024.
33. Beylergil V, Morris PG, Smith-Jones PM, Modi S, Solit D, Hudis CA, Lu Y, O'Donoghue J, Lyashchenko SK, Carrasquillo JA, Larson SM, Akhurst TJ. Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer. Nucl Med Commun 34(12):1157-65, 2013. PMID: 24100444.
34. Wang J, Xia H, Ying Q, Lu Y, Wu Z, Ai F, Ma X. An anatomic consideration of C2 vertebrae artery groove variation for individual screw implantation in axis. Eur Spine J 22(7):1547-52, 2013. e-Pub 2013. PMID: 23661034.
35. Chen D, Cabay RJ, Jin Y, Wang A, Lu Y, Shah-Khan M, Zhou X. MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas. J Oral Maxillofac Res 4(1):e2, 2013. e-Pub 2013. PMID: 24422025.
36. Yang AY, Khiatani V, Lu Y. Lack of liver uptake of 99mTc leukocyte scan in the setting of alcoholic steatohepatitis and dress syndrome. Clin Nucl Med 38(2):140-2, 2013. PMID: 23334132.
37. Ding J, Sun G, Lu Y, Yu BB, Li M, Li L, Li GY, Peng ZH, Zhang XP. Evaluation of anterior ethmoidal artery by 320-slice CT angiography with comparison to three-dimensional spin digital subtraction angiography: initial experiences. Korean J Radiol 13(6):667-73, 2012. e-Pub 2012. PMID: 23118564.
38. Lu Y, Fleming SE, Fields RC, Coit DG, Carrasquillo JA. Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma. Clin Nucl Med 37(8):759-62, 2012. PMID: 22785503.
39. Sun G, Ding J, Lu Y, Li M, Li L, Li GY, Zhang XP. Comparison of standard- and low-tube voltage 320-detector row volume CT angiography in detection of intracranial aneurysms with digital subtraction angiography as gold standard. Acad Radiol 19(3):281-8, 2012. e-Pub 2011. PMID: 22206609.
40. Sun G, Jin P, Li M, Lu Y, Ding J, Liu X, Li F. Percutaneous cementoplasty for painful osteolytic humeral metastases: initial experience with an innovative technique. Skeletal Radiol 40(10):1345-8, 2011. e-Pub 2011. PMID: 21491154.
41. Sun G, Jin P, Li M, Lu Y, Liu X, Li F, Xie Z, Ding J, Peng Z. Percutaneous vertebroplasty for pain management in spinal metastasis with epidural involvement. Technol Cancer Res Treat 10(3):267-74, 2011. PMID: 21517133.
42. Lu Y, Ulaner G. FDG PET/CT demonstration of right atrium metastasis overlooked on contrast-enhanced CT. Clin Nucl Med 36(5):405-6, 2011. PMID: 21467869.
43. Lu Y, Fox JJ. Acute pulmonary embolism detected by perfusion SPECT/CT masquerading as an intermediate probability planar V/Q scan. Clin Nucl Med 35(12):941-3, 2010. PMID: 21206226.
44. Chen F, Luo X, Zhang J, Lu Y, Luo R. Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib. Med Oncol 27(3):950-7, 2010. e-Pub 2009. PMID: 19830603.
45. Sun G, Jin P, Li M, Liu X, Li F, Yu AK, Lu Y. Percutaneous vertebroplasty for treatment of osteolytic metastases of the C2 vertebral body using anterolateral and posterolateral approach. Technol Cancer Res Treat 9(4):417-22, 2010. PMID: 20626207.
46. Sun G, Li M, Lu Y. Unrecognized lithopedion with 35 years' evolution diagnosed on computed tomographic scan. Fertil Steril 94(1):341-2, 2010. e-Pub 2010. PMID: 20116790.
47. Lu Y, O'Reilly EM, Carrasquillo JA. Lack of splenic uptake of In-111 pentetreotide due to splenic embolization. Clin Nucl Med 34(12):960-1, 2009. PMID: 20139851.
48. Lu Y, Fox J, Dunphy M. Coincidental presentations of ganglioneuroma and atypical perforated appendicitis detected by fluorodeoxyglucose positron emission tomography/computed tomography. Clin Nucl Med 34(10):719-21, 2009. PMID: 19893413.
49. Salido EC, Li XM, Lu Y, Wang X, Santana A, Roy-Chowdhury N, Torres A, Shapiro LJ, Roy-Chowdhury J. Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer. Proc Natl Acad Sci U S A 103(48):18249-54, 2006. e-Pub 2006. PMID: 17110443.
50. Ghosh SS, Lu Y, Lee SW, Wang X, Guha C, Roy-Chowdhury J, Roy-Chowdhury N. Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1). Biochem J 392(Pt 3):685-92, 2005. PMID: 16171463.
51. Zhao P, Qin ZL, Ke JS, Lu Y, Liu M, Pan W, Zhao LJ, Cao J, Qi ZT. Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles. FEBS Lett 579(11):2404-10, 2005. PMID: 15848179.
52. Roy-Chowdhury N, Lu Y, Jiang J, Lee S, Guha C, Roy-Chowdhury J.. Comparison of Gene Therapy Strategies for Treatment of Liver Diseases. J. of Gastroenterol. Hepatol 19:S295-301, 2004.
53. Lu Y, Xue Q, Qian WZ, Wang H, Wu MC, Guo YJ. Construction of pGFP-FL plasmid and its application in preparing FL-secreting tumor vaccine. Di Yi Jun Yi Da Xue Xue Bao 22(7):592-5, 2002. PMID: 12376282.
54. Lu Y, Qian W, Wang H, Wu M, Guo Y. Preparation and identification of monoclonal antibody against human CTLA4. J. of Medical Postgraduates 15(2):98-101, 2002.
55. Fu Q, Wang X, Lu Y, Shi X, Yuan H. Long term exposure to morphine down regulate prerodynophin mRNA level in different brain sites of rat. Chinese J. of Drug Dependence 11(2):100-3, 2002.
56. Fu Q, Wang X, Lu Y, Shi X, Lu J, Tang J. Long term exposure to morphine down-regulate preprodynorphine mRNA level in rat hippocampus. U.S. Chinese Journal of Modern Medicine 2(5):74-5, 2001.
57. Fu Q, Wang X, Shi X, Lu Y, Tang J. Inhibitory effect of scopolamine on withdrawal syndromes in morphine dependent rats. J. Sec. Mil. Med. Univ 22(4):351-3, 2001.
58. Lu Y, Li H, Fu J. [Development of a mouse cell line containing stably integrated copies of pMCLacI/Neo plasmid: a model for studying mutations in vitro]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 17(2):125-8, 2000. PMID: 10751538.
59. Lu Y, Li H, Li J, Fu J. Development of pMTR1 plasmid-based transgenic mice model for studying gene mutation. J. Sec. Mil. Med. Univ 21(6):537-40, 2000.
60. Lu Y, LI H, Yao Z, Fu J. Development of a selective system for lac I gene mutants. J. Sec. Mil. Med. Univ 20(10):713-15, 1999.
61. Lu Y, Li H, Fu J. Construction of pMCLacl/Neo plasmid and a new strategy for studying gene mutation. J. Sec. Mil. Med. Univ 20(8):509-12, 1999.
62. Liu Y, Wang H, Liu X Zhou Q, Lu Y, Wang H, Wei L, Wu M, Guo Y. Expression of recombinant human IL-12 by baculovirus/insect cell system and evaluation of its bioactivity in vitro. J. Sec. Mil. Med. Univ 20(8):505-8, 1999.
63. Liu Y, Wang H, Liu X, Zhou Q, Lu Y, Wang H, Wei L, Wu M, Guo Y. Cloning of human IL-12 cDNA. J. Sec. Mil. Med. Univ 20(7):431-3, 1999.

Abstracts

1. Charisma DeSai, Bo Chen, Tinsu Pan, Lu,Y. New Automated Data-Driven Gated Ga-68 DOTATATE PET/CT Technique to Improve Diagnostic Accuracy in Patients with Neuroendocrine Tumors. ARRS Annual Meeting, 2024.
2. Chiyi Xiong, Raymond Wang, Yang Lu, Jianjun Gao and Chun Li. Immuno-PET with 64Cu-labeled antibody–Drug conjugate targeting Nectin-4 in preclinical models of bladder cancer. World Molecular Imaging Society 2023 Annual Meeting, 2023.
3. Freddy Gonzalez, Ricardo Velazquez, Bony Cherian, Richard Wendt III, Homer Macapinlac, Lu,Y, Gregory Ravizzini. Practical Treatment of Lutetium-177 vipivotide textraxetran (Pluvicto®) in a Clinical Setting. Annual Meeting for SNMMI, 2023.
4. Lu,Y, Guofan Xu. Diagnostic Performance of PSMA-based 18F-DCFPyL PET/CT in Prostate Cancer Patients after Definitive Treatment with PSA Level ≤ 0.2 ng/ml. Annuak Meeting for SNMMI, 2023.
5. Zenus J Wilson, Guofan Xu, Sanjit Tewari,Lu,Y. Comparison of PSMA-based 18F- DCFPyL PET/CT and 99mTc-MDP Bone Scan in Detection of Bone Metastasis in Prostate Cancer. Poster Presentation. Annual Meeting for ACNM, 2023.
6. Samer A. Srour, Maria E. Cabanillas, Sonal Gupta, Mark E. Zafereo, Mimi I. Hu, Yang Lu, Ramona Dadu, Shehanie Brana, Melissa Cushing, Scott Avecilla, Theresa Scognamiglio, Moonsoo Jin, Janusz Puc, Gavin Liu, Karrie Du, Asifa Haider, Sebastian A. Mayer, Jingmei Hsu, Thomas J. Fahey, Koen van Besien. Safety and early efficacy of AIC100 CAR T-cell therapy in ICAM-1 positive advanced poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer. 2023 ASCO Annual Meeting 41(16), 2023.
7. Lu Y. ACNM in the Era of Theranostics: Stay Current and Keep Advancing. ACNM Annual Meeting, 2021.
8. Lu Y, Bo Chen, Tharakeswara Bathala, Homer Macapinlac. Comparison of Diagnostic Utility of Fluciclovine PET/CT versus Pelvic Multiparametric MRI for Prostate Cancer in the pelvis in the setting of rising PSA after initial treatment. Annual meeting for ACNM, 2020.
9. Ajalaya Teyateeti, Bilal Khan, Achiraya Teyateeti, Homer Macapinlac, Lu Y. Detection and predictive factor of positive F-18 Fluciclovine PET/CT in post-definitive primary treatment recurrent prostate cancer patients with PSA level < 0.5 ng/ml. Annual meeting for ACNM, 2020.
10. Bo Chen, Peng Wei, Homer A Macapinlac, Lu Y. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP Bone Scan in Detection of Bone Metastasis in Prostate Cancer. SNMMI 2019, 2019.
11. Dong Dai, Tengfei Li, Rahul Mehta, Tinsu Pan, Linghua Wang, Liang Zhang, Michael L. Wang, Hongtu Zhu, Homer A. Macapinlac, Lu Y. Lesion Based Analytics on Pre-therapy FDG PET/CT Radiomics to Predict ibrutinib-resistant mantle cell lymphoma. EANM, 2018.
12. Lu,Y. Lesion Based Analytics On Pretherapy FDG PET/CT Radionics To Predict Ibrutinib-resistant Mantle Cell Lymphoma. EANM, 2018.
13. Lu Y, Macapinlac HA.. Chemotherapy and Immunotherapy induced sarcoid-like reaction or sarcoidosis: a PET/CT pitfall. World Federation of Nuclear Medicine and Biology (WFNMB), 2018.
14. Lu Y. FDG PET/CT for cardiac sarcoidosis evaluation with a 72-hr diet preparation protocol. 2018 SNMMI Mid-Winter & ACNM Annual Meeting, 2018.
15. Lu Y. Lung perfusion SPECT/CT for definitive accurate and clinical relevant diagnosis of pulmonary embolism. 2018 SNMMI Mid-Winter & ACNM Annual Meeting, 2018.
16. Geottl C, Allen A, Patel DDC, Gunasekaran S, Sweiss NJ, Lu Y. Diagnosis of Sarcoid-Associated Aortitis on FDG PET/CT: A Proposed Methodology. Annual meeting for ACNM, 2017.
17. Pate DC, Evers MJ, Gunasekaran S, Goettl C, Patel M, Sweiss NJ, Lu Y. FDG PET/CT findings of cardiac sarcoid are associated with extra thoracic sarcoid. Annual meeting for ACNM, 2017.
18. Gunasekaran S, Goettl C, Patel DC, Lu Y. The Added Value and Cost Savings of Q-SPECT/CT Over V/Q Scan for the Evaluation of Pulmonary Embolus-Charting Outcomes for a Four-Year Experience. Annual meeting for ACNM, 2017.
19. Lu Y, Grant C, Xie K, Sweiss NJ. Suppression of Myocardial 18F-FDG Uptake through Prolonged High-fat Protein and Very Low-carbohydrate Diet before FDG-PET/CT for Evaluation of Patients with Suspected Cardiac Sarcoidosis. Annual meeting for RSNA, 2016.
20. Mehta R, Cai K, Kumar N, Lu Y. A lesion-based Response Prediction model using Pre-therapy PET/CT Image Features for liver-directed Y90 Radioembolization. Annual meeting for ACNM, 2016.
21. Kuei J, Gunasekaran S, Lu Y. FDG distribution pattern tells more than SUV-benign thoracic lymphadenopathy on PET/CT. Annual meeting for ACNM, 2016.
22. Lu Y, Sweiss N. A novel approach to diagnosis cardiac sarcoidosis: combined nuclear stress test and FDG PET/CT with a sophisticated diet preparation protocol. Annual meeting for ACNM, 2015.
23. Lu Y, Kumar N, Xie K, Mar W, Anderson TM, Carney B, Mehta N, Machado R, Blend MJ. Perfusion SPECT/CT Provides Diagnostic Accuracy When Other Pulmonary Embolus Imaging Is Indeterminate. Annual meeting for ACNM, 2015.
24. Mehta R, Kumar N, Lu H, Mariano AT, Knuttinen MG, Anderson TM, Lu Y. Computer Aided Response Prediction Based on Pre-therapy FDG PET/CT Imaging Biomarkers of Y90-SIRT Therapy in Patients with Primary Metastatic Liver Cancers. Annual meeting for RSNA, 2014.
25. Venepalli NK, Gandhi CC, Ozer H, Ho D, Lu Y, Xie H, Berg SA, Chowdhery RA, Gargano MA, Braun AH, Dudek AZ. Phase 1b Study of PGG Beta Glucan in Combination with antiMUC1 antibody (BTH1704) and Gemcitabine for the Treatment of Advanced Pancreatic Cancer. Annual meeting for ASCO, 2014.
26. Mittal N, Zhu B, Behm F, Gaitonde S, Lu Y, Schmidt ML. A unique description of stage iv extranodal marginal zone lymphoma (emzl) in an adolescent associated with gamma heavy chain disease (gammahcd) showing excellent response to bendamustine-rituximab. Annual meeting of American Society of Pediatric Hematology/Oncology (ASPHO), 2014.
27. Lu Y, Elias Y. Comparison of FDG PET/CT and contrast enhanced CT in staging and follow-up of cholangiocarcinoma. Annual meeting for the Society of Nuclear Medicine, 2013.
28. Lu Y, Xie KL, Carney B, Utueyi U, Blend M. Successful implementation of software fusion of perfusion SPECT and low dose noncontrast CT with a simple trinary interpretation strategy as an alternative to CT Pulmonary Angiography in diagnosis of PE. 25th Annual EANM Congress, 2012.
29. Mehta, N, Xie KL, Bresler M, Blend M, Lu Y. Improved diagnostic accuracy of PE with a novel "hybrid imaging" method: transforming ugly duckling into swan. ACNM annual meeting, 2012.
30. Lu Y, Fields RC, Coit DG, Carrasquillo JA. Comparison of 18F-FDG PET/CT and 111In-pentetreotide scan for detection of Merkel cell carcinoma. Annual meeting for the Society of Nuclear Medicine, 2011.

Book Chapters

1. Mariano Jr A, Lu Y. Role of PET/CT in diagnosis and management of choloangiocarcinoma. In: Cholangiocarcinoma: Diagnosis and Treatment. Nova Science Publisher, Inc, 85-100, 2015.
2. Chowdhurry JR, Lu Y, Chowdhury NR. Bilirubin metabolism. In: Oxford Textbook of Hepatology-From Basic Science to Clinical Practice. 3rd. Wiley-Blackwell Oxford: UK, 165-73, 2007.
3. Chowdhury JR, Lu Y, Chowdhury NR. Bilirubin metabolism and its disorders. In: Review of GI Structure and Function Course. American College of Gastroenterology, 107-15, 2005.
4. Chowdhury JR, Lu Y, Chowdhury NR. Bilirubin metabolism and its disorders. In: Review of GI Structure and Function Course. American College of Gastroenterology, 105-14, 2003.
5. Liu Y, Zhao J, Lu Y, Trojan J, Wu M, Guo Y, et al. Antisense IGF-I for hepatocellular carcinoma. In: Hepatocellular Carcinoma Methods and Protocols. Humana Press: Totowa, New Jersey, 221-35, 2000.